Last update:

Medications news

Medications

Late-stage study finds menopause drug fezolinetant safely reduces hot flushes for almost six months

Fezolinetant reduces the frequency and severity of hot flushes during menopause for 24 weeks, without serious side effects, according to research presented at the 26th European Congress of Endocrinology, held 11–14 May, ...

Medications

One in 8 US adults have now used meds like Ozempic, finds poll

About 1 in 8 U.S. adults (12%) have tried a weight-loss drug like Wegovy, Ozempic, Zepbound or Mounjaro, a new KFF Health Tracking Poll says.

Medications

Trifarotene plus skin care beneficial for acne vulgaris

Trifarotene plus skin care is beneficial for patients with moderate acne vulgaris (AV) and acne-induced hyperpigmentation (AIH), according to a study published online April 29 in the International Journal of Dermatology.

Medications

How the drug abemaciclib treats breast cancer

The anti-cancer drug abemaciclib (also known as Vernezio) has been added to the Australian Pharmaceutical Benefits Scheme (PBS) to treat certain types of breast cancer.

Medications

A closed-loop drug-delivery system could improve chemotherapy

When cancer patients undergo chemotherapy, the dose of most drugs is calculated based on the patient's body surface area. This is estimated by plugging the patient's height and weight into an equation, dating to 1916, that ...

Medications

Study finds AI can develop treatments to prevent 'superbugs'

Cleveland Clinic researchers developed an artificial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on how quickly the ...

Medications

Use of acid reflux drugs linked to higher risk of migraine

People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a study published in the April 24, 2024, online issue of Neurology ...

Medications

Follow-up finds landmark steroid study remains safe 50 years on

A study has found there are no adverse long-term cardiovascular health consequences for the now-adult children of mothers who were given corticosteroids because they were at risk of early birth in a landmark trial conducted ...